Abstract Body

Background

A significant proportion (10-20%) of SARS-CoV-2 infected individuals develop Long-COVID (LC), a multisystem disorder with diverse symptoms, among which neurocognitive disturbances (Neuro-LC) are a major public health concern. Here, we evaluate the contribution of immune dysregulation to Neuro-LC in the context of SARS-CoV-2 and Herpesvirus immune responses and viral reactivation.

Methods

We included 132 participants from three COVID-19 cohorts divided into Neuro-LC (n=43), LC (n=29), Recovered (n=28), and Uninfected (n=32) groups. Samples were collected at a median of 603 [344-985] days from last infection and matched by sex and age. We assessed herpesvirus seroprevalence (EBV, CMV, and HHV6) by IgG ELISA and viral reactivation by qPCR in plasma samples. Cryopreserved PBMCs were used to immunophenotype T-cells using markers of lineage (CD3, CD4, CD8, CD45RA, CCR7), Tregs (Foxp3, CD25, CD127) and immune checkpoints (TIGIT, PD1). SARS-CoV-2 and Herpesvirus-specific T-cell responses were assessed by stimulating PBMCs with S1, Nucleocapsid (NC), EBV, CMV and HHV6 peptide pools combining AIMs and functional markers (CD69, CD25, OX40, TNF-α, IFN-γ). Flow cytometry data were analyzed by manual gating and unsupervised FlowSOM.

Results

Neuro-LC and LC participants were mainly female (83%) with a median age of 48 [42-57] years. Cognitive alterations were only observed in Neuro-LC (median 4 [3-4]). 50% of participants were seropositive for EBV, CMV, and HHV6, with no reactivation of herpesvirus in plasma. Regarding T-cell subsets, there was a significant increase in CD8 TEMRA cells in LC (LC vs Recovered; p=0.034). Both CD4 and CD8 SARS-CoV-2-specific T-cell responses were stronger than overall Herpesvirus responses (p<0.0001). Of note, Neuro-LC exhibited elevated CD69+OX40+ NC-specific CD4 T-cells (vs Uninfected; p=0.047). Unsupervised analysis of NC-specific CD4 T-cells defined 21 clusters, of which two differed in Neuro-LC. Cluster 7 showed a reduction in central memory CD4 T-cells (Neuro-LC vs LC; p=0.04), whereas cluster 18 was enriched in effector memory T-cells co-expressing PD1+TIGIT+ and cytokines (Neuro-LC vs Recovered; p=0.019). No differences were observed in S1 and NC-specific CD8 T-cells or Herpesvirus responses.

Conclusions

Our findings support a distinctive immune endotype of Neuro-LC, characterized by an increase in CD69+OX40+ NC-specific CD4 T-cells. These data suggest the persistence of SARS-CoV-2 NC antigen and its possible contribution to the immunopathogenesis of Neuro-LC.